Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.71% | 1.61% | -12.35% | 1.14% | -6.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.98% | 3.23% | -13.22% | 1.69% | -4.62% |
| Operating Income | 13.98% | -3.23% | 13.22% | -7.14% | -20.78% |
| Income Before Tax | 31.00% | 9.05% | 35.86% | -269.01% | 85.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.00% | 9.05% | 35.86% | -269.01% | 85.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.00% | 9.05% | 35.86% | -269.01% | 85.83% |
| EBIT | 13.98% | -3.23% | 13.22% | -7.14% | -20.78% |
| EBITDA | 13.85% | -3.51% | 12.72% | -7.14% | -21.24% |
| EPS Basic | 25.00% | 12.50% | 28.57% | -400.00% | 86.21% |
| Normalized Basic EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS Diluted | 25.00% | 12.50% | 28.57% | -400.00% | 86.21% |
| Normalized Diluted EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
